Document Detail


Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis.
MedLine Citation:
PMID:  20669222     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The intermediate filament nestin is transiently expressed in neural stem/progenitor cells during the development of central nervous system. Recently, increasing evidence has shown that upregulation of nestin is related to malignancy of several cancers, especially glioblastoma. However, the function of nestin in carcinogenesis remains unclear. In this study, we investigated the role of nestin in glioblastoma carcinogenesis by comparing subclones of rat C6 glioblastoma cells that were either high or low for nestin expression. We found that while nestin expression did not influence the in vitro proliferation of glioblastoma cells, subclones characterized by high levels of nestin formed tumors in vivo at significantly faster rates than subclones with low expression. Importantly, C6 subclones that expressed nestin at low levels in vitro were also found to give rise to tumors highly positive for the protein, suggesting that induction of nestin plays an important role in glioblastoma carcinogenesis. Derivation of nestin positive tumors from nestin negative human U87 glioblastoma cells in immunodeficient mice further confirmed that a switch to positive expression of nestin is fundamental to the course of glioblastoma development. Blocking the expression of nestin in glioblastoma tumors via intratumor injection of shRNA significantly slowed tumor growth and volume. These results demonstrated that nestin plays a crucial role in development of glioblastoma and may potentially be targeted for treatment of the disease.
Authors:
Wen Jing Lu; Feng Lan; Qihua He; Andrew Lee; Chad Z Tang; Lin Dong; Baojin Lan; Xiaowen Ma; Joseph C Wu; Li Shen
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-28
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  128     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2011-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  343-51     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 UICC.
Affiliation:
Department of Cell Biology, Peking University Health Science Center, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain Neoplasms / etiology*
Cell Line, Tumor
Glioblastoma / chemistry,  etiology*
Humans
Intermediate Filament Proteins / analysis,  genetics,  physiology*
Intermediate Filaments / chemistry*
Mice
Mice, Inbred BALB C
Mice, Nude
Nerve Tissue Proteins / analysis,  genetics,  physiology*
RNA, Small Interfering / genetics
Rats
Stem Cells / chemistry*
Chemical
Reg. No./Substance:
0/Intermediate Filament Proteins; 0/Nerve Tissue Proteins; 0/RNA, Small Interfering; 0/nestin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancer...
Next Document:  Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.